Dr David Cutter
Clinical Research Fellow (CTSU) and Consultant Clinical Oncologist (Oxford Cancer Centre)
David Cutter studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre. In 2008 he joined CTSU to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013 he was appointed as a Consultant Clinical Oncologist and continues to work within CTSU upon a programme of work investigating the benefits and risks of cancer treatments.
Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.
Taylor C. et al, (2018), J clin oncol, 36, 2288 - 2296
Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods
Ntentas G. et al, (2018), Radiotherapy and oncology, 127, S1091 - S1092
Radiation-induced cardiac toxicity: what have we learnt?
Cutter D., (2018), Radiotherapy and oncology, 127, S1 - S1
Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.
Frobisher C. et al, (2017), Br j cancer, 117, 1723 - 1731
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
Tseng YD. et al, (2017), Int j radiat oncol biol phys, 99, 825 - 842